{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T12:17:00Z","timestamp":1784290620129,"version":"3.55.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:00:00Z","timestamp":1750204800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:00:00Z","timestamp":1750204800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-025-03860-9","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T08:13:25Z","timestamp":1750234405000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Machine learning model for predicting recurrence following intensity-modulated radiation therapy in nasopharyngeal carcinoma"],"prefix":"10.1186","volume":"23","author":[{"given":"Mi","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingxiu","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiliu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nianci","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Libo","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,18]]},"reference":[{"issue":"3","key":"3860_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"3860_CR2","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1097\/CM9.0000000000002108","volume":"135","author":"C Xia","year":"2022","unstructured":"Xia C, Dong X, Li H, et al. Cancer statistics in China and united States, 2022: profiles, trends, and determinants [J]. Chin Med J (Engl). 2022;135(5):584\u201390.","journal-title":"Chin Med J (Engl)"},{"issue":"11","key":"3860_CR3","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41571-021-00524-x","volume":"18","author":"KC Wong","year":"2021","unstructured":"Wong KC, W, Hui EP, Lo K-W, et al. Nasopharyngeal carcinoma: an evolving paradigm [J]. Nat Rev Clin Oncol. 2021;18(11):679\u201395.","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"3860_CR4","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.radonc.2012.08.013","volume":"104","author":"G Peng","year":"2012","unstructured":"Peng G, Wang T, Yang K-Y, et al. A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma [J]. Radiother Oncol. 2012;104(3):286\u201393.","journal-title":"Radiother Oncol"},{"key":"3860_CR5","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.oraloncology.2017.12.004","volume":"77","author":"KH Au","year":"2018","unstructured":"Au KH, Ngan RKC, Ng AW, Y, et al. Treatment outcomes of nasopharyngeal carcinoma in modern era after intensity modulated radiotherapy (IMRT) in Hong Kong: A report of 3328 patients (HKNPCSG 1301 study) [J]. Oral Oncol. 2018;77:16\u201321.","journal-title":"Oral Oncol"},{"issue":"3","key":"3860_CR6","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.radonc.2013.10.020","volume":"110","author":"X Sun","year":"2014","unstructured":"Sun X, Su S, Chen C, et al. Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: an analysis of survival and treatment toxicities [J]. Radiother Oncol. 2014;110(3):398\u2013403.","journal-title":"Radiother Oncol"},{"issue":"8","key":"3860_CR7","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1002\/hed.23719","volume":"37","author":"X Zou","year":"2015","unstructured":"Zou X, Han F, Ma W-J, et al. Salvage endoscopic nasopharyngectomy and intensity-modulated radiotherapy versus conventional radiotherapy in treating locally recurrent nasopharyngeal carcinoma [J]. Head Neck. 2015;37(8):1108\u201315.","journal-title":"Head Neck"},{"issue":"6","key":"3860_CR8","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/S1470-2045(15)70126-9","volume":"16","author":"P Blanchard","year":"2015","unstructured":"Blanchard P, Lee A, Marguet S, et al. Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis [J]. Lancet Oncol. 2015;16(6):645\u201355.","journal-title":"Lancet Oncol"},{"issue":"7","key":"3860_CR9","doi-asserted-by":"publisher","first-page":"e0219611","DOI":"10.1371\/journal.pone.0219611","volume":"14","author":"T Du","year":"2019","unstructured":"Du T, Xiao J, Qiu Z, et al. The effectiveness of intensity-modulated radiation therapy versus 2D-RT for the treatment of nasopharyngeal carcinoma: A systematic review and meta-analysis [J]. PLoS ONE. 2019;14(7):e0219611.","journal-title":"PLoS ONE"},{"issue":"12","key":"3860_CR10","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1056\/NEJMoa1905287","volume":"381","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Chen L, Hu G-Q, et al. Gemcitabine and cisplatin induction chemotherapy in nasopharyngeal carcinoma [J]. N Engl J Med. 2019;381(12):1124\u201335.","journal-title":"N Engl J Med"},{"issue":"9","key":"3860_CR11","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s11912-020-00949-0","volume":"22","author":"C-Y Hao","year":"2020","unstructured":"Hao C-Y, Hao S-P. The management of rNPC: salvage surgery vs. Re-irradiation [J]. Curr Oncol Rep. 2020;22(9):86.","journal-title":"Curr Oncol Rep"},{"issue":"8","key":"3860_CR12","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1002\/alr.22552","volume":"10","author":"J Yang","year":"2020","unstructured":"Yang J, Song X, Sun X, et al. Outcomes of recurrent nasopharyngeal carcinoma patients treated with endoscopic nasopharyngectomy: a meta-analysis [J]. Int Forum Allergy Rhinol. 2020;10(8):1001\u201311.","journal-title":"Int Forum Allergy Rhinol"},{"issue":"3","key":"3860_CR13","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/S0360-3016(03)01508-6","volume":"58","author":"T-X Lu","year":"2004","unstructured":"Lu T-X, Mai W-Y, Teh BS, et al. Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma [J]. Int J Radiat Oncol Biol Phys. 2004;58(3):682\u20137.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"12","key":"3860_CR14","doi-asserted-by":"publisher","first-page":"3979","DOI":"10.1002\/hed.26836","volume":"43","author":"E Newton","year":"2021","unstructured":"Newton E, Valenzuela D, Foley J, et al. Outcomes for the treatment of locoregional recurrent nasopharyngeal cancer: systematic review and pooled analysis [J]. Head Neck. 2021;43(12):3979\u201395.","journal-title":"Head Neck"},{"key":"3860_CR15","doi-asserted-by":"crossref","unstructured":"Simo R, Robinson M, Lei M et al. Nasopharyngeal carcinoma: united Kingdom National multidisciplinary guidelines [J]. J Laryngol Otol, 2016, 130(S2).","DOI":"10.1017\/S0022215116000517"},{"issue":"3","key":"3860_CR16","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.ijrobp.2021.01.041","volume":"110","author":"WT Ng","year":"2021","unstructured":"Ng WT, Soong YL, Ahn YC, et al. International recommendations on reirradiation by intensity modulated radiation therapy for locally recurrent nasopharyngeal carcinoma [J]. Int J Radiat Oncol Biol Phys. 2021;110(3):682\u201395.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"11","key":"3860_CR17","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1002\/cac2.12218","volume":"41","author":"L-L Tang","year":"2021","unstructured":"Tang L-L, Chen Y-P, Chen C-B, et al. The Chinese society of clinical oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma [J]. Cancer Commun (Lond). 2021;41(11):1195\u2013227.","journal-title":"Cancer Commun (Lond)"},{"issue":"12","key":"3860_CR18","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1177\/0003489417734229","volume":"126","author":"L Wang","year":"2017","unstructured":"Wang L, Guo Y, Xu J, et al. Clinical analysis of recurrence patterns in patients with nasopharyngeal carcinoma treated with Intensity-Modulated radiotherapy [J]. Ann Otol Rhinol Laryngol. 2017;126(12):789\u201397.","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"1","key":"3860_CR19","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1245\/s10434-010-1292-9","volume":"18","author":"L Zhang","year":"2011","unstructured":"Zhang L, Zhu Y-x, Wang Y, et al. Salvage surgery for neck residue or recurrence of nasopharyngeal carcinoma: a 10-year experience [J]. Ann Surg Oncol. 2011;18(1):233\u20138.","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"3860_CR20","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1245\/s10434-011-2018-3","volume":"19","author":"W-C Lo","year":"2012","unstructured":"Lo W-C, Wang C-P, Ko J-Y, et al. Salvage treatment for isolated regional failure of nasopharyngeal carcinoma after primary radiotherapy [J]. Ann Surg Oncol. 2012;19(3):1001\u20138.","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"3860_CR21","doi-asserted-by":"publisher","first-page":"3056","DOI":"10.1245\/s10434-014-3683-9","volume":"21","author":"S Na\u2019ara","year":"2014","unstructured":"Na\u2019ara S, Amit M, Billan S, et al. Outcome of patients undergoing salvage surgery for recurrent nasopharyngeal carcinoma: a meta-analysis [J]. Ann Surg Oncol. 2014;21(9):3056\u201362.","journal-title":"Ann Surg Oncol"},{"key":"3860_CR22","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.radonc.2019.09.001","volume":"141","author":"J Wang","year":"2019","unstructured":"Wang J, Qing G, Ou X, et al. The impact of target dosimetry on patients\u2019 locoregional recurrence in nasopharyngeal carcinoma: A propensity score-matched analysis [J]. Radiother Oncol. 2019;141:67\u201371.","journal-title":"Radiother Oncol"},{"issue":"1","key":"3860_CR23","doi-asserted-by":"publisher","first-page":"227","DOI":"10.20892\/j.issn.2095-3941.2019.0263","volume":"17","author":"X Li","year":"2020","unstructured":"Li X, Lin C, Yan J, et al. Establishment of a prognostic scoring model for regional recurrent nasopharyngeal carcinoma after neck dissection [J]. Cancer Biol Med. 2020;17(1):227\u201336.","journal-title":"Cancer Biol Med"},{"issue":"10","key":"3860_CR24","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1016\/j.ejca.2013.03.008","volume":"49","author":"X-b Wan","year":"2013","unstructured":"Wan X-b, Wei L, Li H, et al. High pretreatment serum lactate dehydrogenase level correlates with disease relapse and predicts an inferior outcome in locally advanced nasopharyngeal carcinoma [J]. Eur J Cancer. 2013;49(10):2356\u201364.","journal-title":"Eur J Cancer"},{"issue":"1","key":"3860_CR25","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/cac2.12113","volume":"41","author":"C-F Wu","year":"2021","unstructured":"Wu C-F, Lv J-W, Lin L, et al. Development and validation of a web-based calculator to predict individualized conditional risk of site-specific recurrence in nasopharyngeal carcinoma: analysis of 10,058 endemic cases [J]. Cancer Commun (Lond). 2021;41(1):37\u201350.","journal-title":"Cancer Commun (Lond)"},{"issue":"5","key":"3860_CR26","doi-asserted-by":"publisher","first-page":"e2110703","DOI":"10.1001\/jamanetworkopen.2021.10703","volume":"4","author":"J Herrin","year":"2021","unstructured":"Herrin J, Abraham NS, Yao X, et al. Comparative effectiveness of machine learning approaches for predicting Gastrointestinal bleeds in patients receiving antithrombotic treatment [J]. JAMA Netw Open. 2021;4(5):e2110703.","journal-title":"JAMA Netw Open"},{"key":"3860_CR27","doi-asserted-by":"crossref","unstructured":"Riley RD, Ensor J, Snell KIE et al. Calculating the sample size required for developing a clinical prediction model [J]. BMJ, 2020, 368m441.","DOI":"10.1136\/bmj.m441"},{"key":"3860_CR28","doi-asserted-by":"crossref","unstructured":"Oei RW, Lyu Y, Ye L et al. Progression-Free survival prediction in patients with nasopharyngeal carcinoma after Intensity-Modulated radiotherapy: machine learning vs. Traditional statistics [J]. J Pers Med, 2021, 11(8).","DOI":"10.3390\/jpm11080787"},{"key":"3860_CR29","doi-asserted-by":"crossref","unstructured":"Akcay M, Etiz D, Celik O et al. Evaluation of Prognosis in Nasopharyngeal Cancer Using Machine Learning [J]. Technol Cancer Res Treat, 2020, 19(1533033820909829.","DOI":"10.1177\/1533033820909829"},{"issue":"3","key":"3860_CR30","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1093\/eurheartj\/ehz565","volume":"41","author":"SJ Al\u2019aref","year":"2020","unstructured":"Al\u2019aref SJ, Maliakal G, Singh G, et al. Machine learning of clinical variables and coronary artery calcium scoring for the prediction of obstructive coronary artery disease on coronary computed tomography angiography: analysis from the CONFIRM registry [J]. Eur Heart J. 2020;41(3):359\u201367.","journal-title":"Eur Heart J"},{"issue":"4","key":"3860_CR31","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.annonc.2020.12.007","volume":"32","author":"P Bossi","year":"2021","unstructured":"Bossi P, Chan AT, Licitra L, et al. Nasopharyngeal carcinoma: ESMO-EURACAN clinical practice guidelines for diagnosis, treatment and follow-up\u2020 [J]. Ann Oncol. 2021;32(4):452\u201365.","journal-title":"Ann Oncol"},{"issue":"6","key":"3860_CR32","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1044579X02000913","volume":"12","author":"KCA Chan","year":"2002","unstructured":"Chan KCA, Lo YMD. Circulating EBV DNA as a tumor marker for nasopharyngeal carcinoma [J]. Semin Cancer Biol. 2002;12(6):489\u201396.","journal-title":"Semin Cancer Biol"},{"key":"3860_CR33","doi-asserted-by":"crossref","unstructured":"Xue F, He X. Epstein-Barr virus DNA in nasopharyngeal carcinoma: A brief review [J]. Methods Mol Biol, 2020, 2204(.","DOI":"10.1007\/978-1-0716-0904-0_9"},{"issue":"10","key":"3860_CR34","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1056\/NEJMx180004","volume":"378","author":"Analysis of Plasma Epstein","year":"2018","unstructured":"Analysis of Plasma Epstein-. Barr virus DNA to screen for nasopharyngeal Cancer [J]. N Engl J Med. 2018;378(10):973.","journal-title":"N Engl J Med"},{"issue":"3","key":"3860_CR35","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/S1470-2045(18)30080-9","volume":"19","author":"X-R Tang","year":"2018","unstructured":"Tang X-R, Li Y-Q, Liang S-B, et al. Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort study [J]. Lancet Oncol. 2018;19(3):382\u201393.","journal-title":"Lancet Oncol"},{"issue":"9","key":"3860_CR36","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1200\/JCO.2017.75.5165","volume":"36","author":"YQ Li","year":"2018","unstructured":"Li YQ, Tian YM, Tan SH, et al. Prognostic model for stratification of radioresistant nasopharynx carcinoma to curative salvage radiotherapy [J]. J Clin Oncol. 2018;36(9):891\u20139.","journal-title":"J Clin Oncol"},{"key":"3860_CR37","unstructured":"Tang L-Q, Li C-F, Li J et al. Establishment and validation of prognostic nomograms for endemic nasopharyngeal carcinoma [J]. J Natl Cancer Inst, 2016, 108(1)."},{"issue":"9","key":"3860_CR38","doi-asserted-by":"publisher","first-page":"5672","DOI":"10.1097\/JS9.0000000000001752","volume":"110","author":"H Jiang","year":"2024","unstructured":"Jiang H, Zuo M, Li W, et al. Multimodal imaging-based prediction of recurrence for unresectable HCC after downstage and resection-cohort study [J]. Int J Surg. 2024;110(9):5672\u201384.","journal-title":"Int J Surg"},{"issue":"13","key":"3860_CR39","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.1158\/1078-0432.CCR-23-3978","volume":"30","author":"JW Han","year":"2024","unstructured":"Han JW, Lee SK, Kwon JH, et al. A machine learning algorithm facilitates prognosis prediction and treatment selection for Barcelona clinic liver Cancer stage C hepatocellular carcinoma [J]. Clin Cancer Res. 2024;30(13):2812\u201321.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"3860_CR40","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1186\/s12967-024-05203-w","volume":"22","author":"B Dong","year":"2024","unstructured":"Dong B, Zhang H, Duan Y, et al. Development of a machine learning-based model to predict prognosis of alpha-fetoprotein-positive hepatocellular carcinoma [J]. J Transl Med. 2024;22(1):455.","journal-title":"J Transl Med"},{"issue":"11","key":"3860_CR41","doi-asserted-by":"publisher","first-page":"e796","DOI":"10.1016\/S2589-7500(22)00170-4","volume":"4","author":"EK Oikonomou","year":"2022","unstructured":"Oikonomou EK, Spatz ES, Suchard MA, et al. Individualising intensive systolic blood pressure reduction in hypertension using computational trial phenomaps and machine learning: a post-hoc analysis of randomised clinical trials [J]. Lancet Digit Health. 2022;4(11):e796\u2013805.","journal-title":"Lancet Digit Health"},{"key":"3860_CR42","doi-asserted-by":"crossref","unstructured":"Clift AK, Dodwell D, Lord S et al. Development and internal-external validation of statistical and machine learning models for breast cancer prognostication: cohort study [J]. BMJ, 2023, 381e073800.","DOI":"10.1136\/bmj-2022-073800"},{"issue":"9","key":"3860_CR43","doi-asserted-by":"publisher","first-page":"e571","DOI":"10.1016\/S2589-7500(23)00113-9","volume":"5","author":"AK Clift","year":"2023","unstructured":"Clift AK, Collins GS, Lord S, et al. Predicting 10-year breast cancer mortality risk in the general female population in England: a model development and validation study [J]. Lancet Digit Health. 2023;5(9):e571\u201381.","journal-title":"Lancet Digit Health"},{"key":"3860_CR44","doi-asserted-by":"crossref","unstructured":"Lu Z-J, Liu L-T, Sun X-S et al. Establishment and validation of a prognostic nomogram to predict early metastasis in nasopharyngeal carcinoma patients within six months after radiotherapy and to guide intensive treatment [J]. Radiother Oncol, 2021;162(202\u2013\u200911.","DOI":"10.1016\/j.radonc.2021.03.035"},{"issue":"11","key":"3860_CR45","doi-asserted-by":"publisher","first-page":"6939","DOI":"10.21037\/tcr-20-2080","volume":"9","author":"G Yang","year":"2020","unstructured":"Yang G, Luo B, Yang Q, et al. Construction of nomograms for nasopharyngeal carcinoma containing primary tumor size and SEER stage [J]. Transl Cancer Res. 2020;9(11):6939\u201354.","journal-title":"Transl Cancer Res"},{"issue":"1","key":"3860_CR46","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1186\/s12935-021-02158-6","volume":"21","author":"N Xue","year":"2021","unstructured":"Xue N, Ou G, Ma W, et al. Development and validation of a risk prediction score for patients with nasopharyngeal carcinoma [J]. Cancer Cell Int. 2021;21(1):452.","journal-title":"Cancer Cell Int"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-03860-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-025-03860-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-03860-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T08:13:27Z","timestamp":1750234407000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-025-03860-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,18]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3860"],"URL":"https:\/\/doi.org\/10.1186\/s12957-025-03860-9","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,18]]},"assertion":[{"value":"21 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with Good Clinical Practice Guidelines and the Declaration of Helsinki. The plan and amendments have been approved by the Ethics Committee of The First Affiliated Hospital of Zhejiang University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"237"}}